sec.160Record when selling S4 medicine

sec.160 Record when selling S4 medicine

As soon as practicable after selling an S4 medicine for a patient, a pharmacist must make and keep a record of the following information— the name of the pharmacist; the date the medicine is sold; the name and address of the patient; for a monitored medicine—the date of birth of the patient; the name of the medicine or other sufficient information to accurately identify the medicine; the approved name or brand name of the medicine a description of the medicine compounded the form, strength and amount of the medicine sold; the instructions given for the use of the medicine; the name of the prescriber who last prescribed the medicine to the person, if known; a brief description of why the pharmacist is selling the medicine. See section 224 about keeping records. s 160 amd 2025 SL No. 60 s 12

• (a) the name of the pharmacist;
• (b) the date the medicine is sold;
• (c) the name and address of the patient;
• (d) for a monitored medicine—the date of birth of the patient;
• (e) the name of the medicine or other sufficient information to accurately identify the medicine; Examples— • the approved name or brand name of the medicine • a description of the medicine compounded
• • the approved name or brand name of the medicine
• • a description of the medicine compounded
• (f) the form, strength and amount of the medicine sold;
• (g) the instructions given for the use of the medicine;
• (h) the name of the prescriber who last prescribed the medicine to the person, if known;
• (i) a brief description of why the pharmacist is selling the medicine.
• • the approved name or brand name of the medicine
• • a description of the medicine compounded